Abstract
A total of 451 extraintestinal, clinically relevant strains of theKlebsiella, Enterobacter andSerratia spp. isolated over a nine-month period from hospitalized patients at four different centers in Italy were investigated. Identification using the API 20E system showed that isolates belonged to 12 different species. Overall, strains ofKlebsiella, Enterobacter andSerratia were in a ratio of approximately 3.4:2:1. Fifty-nine per cent of all strains were from urinary specimens, 12% from respiratory secretions, 10% from wounds and abscesses, and lower percentages from other sources. All strains were tested for their susceptibility to ten antibiotics. The rate of resistance to most drugs was generally greater inEnterobacter andSerratia than inKlebsiella. The overall incidence of strains of the intermediate category (i.e. between full sensitivity and resistance) was unexpectedly high. Both the relative frequency and the antibiotic susceptibility of strains of the various species varied from center to center; possible reasons for such differences are examined.
Similar content being viewed by others
References
Farmer, J. J., Davis, B. R., Hickman-Brenner, F. W., McWorther, A., Huntley-Carter, G. P., Asbury, M. A., Riddle, C., Wathen-Grady, W. G., Elias, C., Fanning, G. R., Steigerwalt, A. G., O'Hara, C. M., Morris, G. K., Smith, P. B., Brenner, D. J.: Biochemical identification of new species and biogroups ofEnterobacteriaceae isolated from clinical specimens. Journal of Clinical Microbiology 1985, 21: 46–76.
National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A3. Villanova, PA, 1984.
National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. First informational supplement M100-S. Villanova, PA, 1986.
Grimont, P. A. D., Grimont, F., Richard, C., Davis, B. R., Steigerwalt, A. G., Brenner, D. J.: Deoxyribonucleic acid relatedness betweenSerratia plymuthica and otherSerratia species, with a description ofSerratia odorifera sp. nov. (type strain: ICPB 3995). International Journal of Systematic Bacteriology 1978, 28: 453–463.
Farmer, J. J., Ashbury, M. A., Hickman, F. W., Brenner, D. J., and theEnterobacteriaceae Study Group.Enterobacter sakazakii: new species of “Enterobacteriaceae” isolated from clinical specimens. International Journal of Systematic Bacteriology 1980, 30: 569–584.
Muytjens, H. L., Zanen, H. C., Sonderkamp, H. J., Kollée, L. A., Wachsmuth, I. K., Farmer, J. J.: Analysis of eight cases of neonatal meningitis and sepsis due toEnterobacter sakazakii. Journal of Clinical Microbiology 1983, 18: 115–120.
Izard, D., Gavini, F., Leclerc, H.: Polynucleotide sequence relatedness and genome size amongEnterobacter intermedium sp. nov. and the speciesEnterobacter cloacae andKlebsiella pneumoniae. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene (C) 1980, 1: 51–60.
Prats, G., Richard, C., Mirelis, B., Lopez, P.: Human isolates ofEnterobacter intermedium Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene (A) 1987, 266: 422–424.
Atkinson, B. A.: Species incidence and trends of susceptibility to antibiotics in the United States and other countries: MIC and MBC. In: Lorian, V. (ed.): Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, 1986, p. 995–1162.
Kresken, M., Wiedemann, B.: Development of resistance in the past decade in central Europe. Journal of Antimicrobial Chemotherapy 1986, 18, Supplement C: 235–242.
O'Brien, T. F., and the Members of Task Force 2.: Resistance of bacteria to antibacterial agents: report of Task Force 2. Reviews of Infectious Diseases 1987, 9, Supplement 3: 244–260.
Ellner, P. D., Fink, D. J., Neu, H. C., Parry, M. F.: Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates. Journal of Clinical Microbiology 1987, 25: 1668–1674.
O'Brien, T. F., Mayer, K. H., Hopkins, J. D., Farrell, J. J., Chao, L., Kent, R. L.: Resistance to antibiotics in clinical isolates ofKlebsiella pneumoniae. Infection Control 1985, 6: 64–67.
Sanders, C. C.: Novel resistance selected by the new expanded-spectrum cephalosporins: a concern. Journal of Infectious Diseases 1983, 147: 585–589.
Seeberg, A. H., Tolxdorff-Neutzling, R. M., Wiedemann, B.: Chromosomalβ-lactamase ofEnterobacter cloacae are responsible for resistance to third-generation cephalosporins. Antimicrobial Agents and Chemotherapy 1983, 23: 918–925.
Aronoff, S. C., Shlaes, D. M.: Factors that influence the evolution ofβ-lactamase-inducible strains ofEnterobacter cloacae andPseudomonas aeruginosa. Journal of Infectious Diseases 1987, 155: 936–941.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Varaldo, P.E., Biavasco, F., Mannelli, S. et al. Distribution and antibiotic susceptibility of extraintestinal clinical isolates ofKlebsiella, Enterobacter andSerratia species. Eur. J. Clin. Microbiol. Infect. Dis. 7, 495–500 (1988). https://doi.org/10.1007/BF01962599
Issue Date:
DOI: https://doi.org/10.1007/BF01962599